Informações:

Synopsis

LymeMIND is designed to enable a systems medicine approach to identify novel biomarkers and new therapeutic opportunities. Through our network of collaborators, we are able to interrogate the complex biology of samples collected from Lyme-affected individuals using molecular profiling technologies and applying advanced statistical and machine learning approaches to move rapidly from “Big Data” to knowledge and improved understanding of the disease.   About My Guest: Patricia Savi Glowe is the Director of Operations for the Institute for Next Generation Healthcare (INGH) in the Icahn School of Medicine Mount Sinai, and the Director of Strategy & Operations for the Precision Health Enterprise (PHE) in the Mount Sinai Health System. She leads the organization and development of research programs and directs operational efforts supporting the entirety of INGH, PHE, and associated centers. She joined Mount Sinai's Department of Genetics and Genomic Sciences in January 2013 and began her current work with Dr. D